Literature DB >> 10987254

Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma.

N Cingolani1, R Shaco-Levy, A Farruggio, D S Klimstra, J Rosai.   

Abstract

Five cases of pancreatic neoplasms accompanied by production of alpha-fetoprotein (AFP) and serum elevation of this marker are presented, and the better-documented cases of this phenomenon from the literature are reviewed. Four of the cases originated in the orthotopic pancreas, whereas the fifth arose in the pancreatic component of a mediastinal teratoma. The patients were children or young adults. AFP production in pancreatic tumors is closely linked to acinar differentiation, most cases representing either pancreatoblastoma or acinar cell carcinoma. The distinction between these 2 tumors may be difficult because of the many morphologic and immunohistochemical features they share.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987254     DOI: 10.1053/hupa.2000.9075

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  17 in total

1.  Cushing's syndrome in a child with pancreatic acinar cell carcinoma.

Authors:  György Illyés; Andrea Luczay; Gábor Benyó; Attila Kálmán; Katalin Borka; Katalin Köves; Károly Rácz; Tivadar Tulassay; Zsuzsa Schaff
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

2.  Alpha-fetoprotein-producing colon cancer with atypical bulky lymph node metastasis.

Authors:  Kuangi Fu; Akihiro Kobayashi; Norio Saito; Yasushi Sano; Shigeharu Kato; Hiroaki Ikematsu; Takahiro Fujimori; Yasushi Kaji; Shigeaki Yoshida
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

3.  α-fetoprotein involvement during glucocorticoid-induced precocious maturation in rat colon.

Authors:  Min Chen; Peng Sun; Xiao-Yan Liu; Dan Dong; Jun Du; Luo Gu; Ying-Bin Ge
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

Review 4.  Aggressive approach to acinar cell carcinoma of the pancreas: a single-institution experience and a literature review.

Authors:  Giovanni Butturini; Michele Pisano; Aldo Scarpa; Mirko D'Onofrio; Alessandra Auriemma; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2010-08-28       Impact factor: 3.445

5.  Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.

Authors:  Susan C Abraham; Tsung-Teh Wu; Ralph H Hruban; Jae-Hyuk Lee; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; David S Klimstra
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

6.  Primary mixed germ cell tumor of the liver with sarcomatous components.

Authors:  Ai-Min Xu; Shao-Juan Gong; Wei-Hua Song; Xiao-Wei Li; Chun-Hua Pan; Jun-Jun Zhu; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

7.  Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature.

Authors:  Akhil K Seth; Pedram Argani; Kurtis A Campbell; John L Cameron; Timothy M Pawlik; Richard D Schulick; Michael A Choti; Christopher L Wolfgang
Journal:  J Gastrointest Surg       Date:  2007-10-24       Impact factor: 3.452

8.  Primary acinar cell carcinoma of the liver.

Authors:  Valérie Hervieu; Catherine Lombard-Bohas; Jérôme Dumortier; Olivier Boillot; Jean-Yves Scoazec
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

9.  Expression and location of alpha-fetoprotein during rat colon development.

Authors:  Xiao-Yan Liu; Dan Dong; Peng Sun; Jun Du; Luo Gu; Ying-Bin Ge
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

10.  Dexamethasone treatment induces the reprogramming of pancreatic acinar cells to hepatocytes and ductal cells.

Authors:  Amani Al-Adsani; Zoë D Burke; Daniel Eberhard; Katherine L Lawrence; Chia-Ning Shen; Anil K Rustgi; Hiroshi Sakaue; J Mark Farrant; David Tosh
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.